Cardiovascular calcification refers to the abnormal accumulation of calcium deposits in the blood vessels and heart tissues, a process commonly associated with various cardiovascular diseases. These deposits, primarily composed of calcium phosphate crystals, can lead to the stiffening and narrowing of arteries, diminishing their elasticity and obstructing blood flow. The most common forms of cardiovascular calcification involve the coronary arteries, heart valves, and the aorta. Atherosclerosis, a condition characterized by the buildup of fatty plaques in the arterial walls, often precedes and contributes to this calcification. The presence of calcification increases the risk of serious complications such as heart attacks and strokes. Detection of cardiovascular calcification is typically accomplished through imaging techniques like computed tomography (CT) scans. Management and prevention strategies involve lifestyle modifications, including a heart-healthy diet, regular exercise, and medications aimed at controlling risk factors such as cholesterol levels and blood pressure. Understanding and addressing cardiovascular calcification play crucial roles in the overall management of cardiovascular health and the prevention of associated complications.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India